Effective blockade of RAAS by combination of aliskiren and olmesartan improves glucose homeostasis, glomerular filtration rate along with renal variables in streptozotocin induced diabetic rats-Reference-Cited by-同舟云学术

Effective blockade of RAAS by combination of aliskiren and olmesartan improves glucose homeostasis, glomerular filtration rate along with renal variables in streptozotocin induced diabetic rats

Published:2012-05 Issue:1-2 Volume:46 Page:32-42
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Gandhi Sonia,Srinivasan B.P.,Akarte Atul Sureshrao

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference69 articles.

1. Role of local and systemic angiotensin in diabetic renal disease;Anderson;Kid. Intl.,1997

2. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy;Atkins;Am. J. Kid. Dis.,2005

3. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption;Azizi;J. Am. Soc. Nephrol.,2004

4. Birkenhäger, W.H., Staessen, J.A., 2007. Dual inhibition of the renin system by aliskiren and valsartan. www.thelancet.com. 370(9583), 195–196.

5. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease;Brenner;Kid Intl.,1983

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of the renin inhibitor aliskiren on neuronal toxic damage;PHARMAZIE;2021

2. Effects of combined treatment with blood flow restriction and low-current electrical stimulation on capillary regression in the soleus muscle of diabetic rats;Journal of Applied Physiology;2021-10-01

3. Radix Rehmanniae and Corni Fructus against Diabetic Nephropathy via AGE-RAGE Signaling Pathway;Journal of Diabetes Research;2020-12-02

4. NiaoDuQing granules relieve chronic kidney disease symptoms by decreasing renal fibrosis and anemia;Oncotarget;2017-06-14

5. Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease;Pharmacology & Therapeutics;2016-08